Tirzepatide and semaglutide are the two GLP-1 medications most people are deciding between. Both are once-weekly injections, both reduce appetite, and both help people lose a meaningful amount of weight. They are not the same, though, and since 2025 there is a large head-to-head trial showing how they compare.
This guide covers how each one works, what the research found, who tends to choose each, and how to start.
The short answer
For most people, tirzepatide is the one to discuss first. It works on two appetite hormones instead of one, and in SURMOUNT-5, the first large trial to compare the FDA-approved versions directly, it led to more weight loss on average: 20.2% of body weight compared with 13.7% over 72 weeks.
Important: SURMOUNT-5 studied specific FDA-approved tirzepatide and semaglutide regimens. Avono compounded medications were not studied in SURMOUNT-5, are not FDA-approved, and individual results vary.
How they work
Both medications copy hormones your gut releases after you eat. Those hormones tell your brain you are full, slow how fast your stomach empties and help control blood sugar.
- Semaglutide acts on one hormone pathway, GLP-1 (glucagon-like peptide-1).
- Tirzepatide acts on GLP-1 and a second pathway, GIP (glucose-dependent insulinotropic polypeptide). Working on both is the main reason researchers expected it to produce more weight loss, and it is what SURMOUNT-5 was designed to test.
What the head-to-head trial found
SURMOUNT-5 enrolled 751 adults with obesity who did not have type 2 diabetes and randomly assigned them to the highest dose they could tolerate of tirzepatide (10 or 15 mg) or semaglutide (1.7 or 2.4 mg) for 72 weeks. It was published in the New England Journal of Medicine in 2025.
| Result at 72 weeks (SURMOUNT-5) | Tirzepatide | Semaglutide |
|---|---|---|
| Average weight reduction | 20.2% | 13.7% |
| Average waist reduction | 18.4 cm | 13.0 cm |
| Lost 10% or more of body weight | 81.6% | 60.5% |
| Lost 15% or more | 64.6% | 40.1% |
| Lost 20% or more | 48.4% | 27.3% |
| Lost 25% or more | 31.6% | 16.1% |
The difference in average weight loss was statistically significant. Tirzepatide also roughly doubled the share of people who lost 20% or 25% of their body weight. Results varied widely in both groups: some people lost much more than the average, and some lost less.
The trial was open-label and sponsored by Eli Lilly, the maker of tirzepatide. Neither fact changes the result, but both are worth knowing.
What other research shows
- Tirzepatide, SURMOUNT-1: adults lost an average of 15.0% to 20.9% of body weight over 72 weeks, depending on dose.
- Tirzepatide over three years: in the SURMOUNT-1 extension for adults with prediabetes, weight loss held at about 12% to 20% at 176 weeks, and 1.3% of people taking tirzepatide were diagnosed with type 2 diabetes, compared with 13.3% on placebo.
- Semaglutide, STEP 1: adults lost an average of 14.9% of body weight over 68 weeks.
- Semaglutide, SELECT: the FDA-approved product reduced major heart events in adults with heart disease and overweight or obesity.
These are separate trials with different people, so their numbers can’t be compared directly. That is why SURMOUNT-5 matters most for this decision.
Side effects
Side effects in SURMOUNT-5 were similar for both medications: mostly nausea, diarrhea, vomiting and constipation, usually mild to moderate and most common while the dose is going up. Starting low and increasing slowly helps, and so do smaller meals.
If nausea is a concern, you can add ondansetron, an anti-nausea tablet, during your Avono GLP-1 intake. Your clinician decides whether it is right for you.
Neither medication is used during pregnancy or by people with a personal or family history of medullary thyroid cancer or MEN 2. A clinician reviews your health history before prescribing either one.
Why most people start with tirzepatide
- More weight loss on average in the only large head-to-head trial.
- Two hormone pathways instead of one.
- Long-term data: weight loss held over three years in SURMOUNT-1.
- More than weight: the FDA-approved version is also approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
- One price at every dose level at Avono, so your cost doesn’t rise as your dose does.
When semaglutide may make sense
Semaglutide has the longer track record, including the SELECT heart-outcomes trial of the FDA-approved product. It can be a good fit if you are already doing well on it, if a clinician advises it for your health history, or if a lower monthly price is the deciding factor. It is available at Avono too; you can see semaglutide here.
What it costs at Avono
Your secure clinical intake will open in a new tab.
Tirzepatide is one monthly price at every Avono dose level, with no clinician fee, no membership fee and free shipping. Your payment is completed only if a clinician prescribes treatment, and you can cancel anytime.
Add to your GLP-1 treatment
Choose these during your GLP-1 intake. There is no separate visit, and a licensed clinician decides whether each one is right for you.
Nausea support
Ondansetron ODT 4 mg
$45 for 20 tablets, taken as needed
An anti-nausea tablet that dissolves on the tongue. Take it only when you need it.
Sleep support
Trazodone
50, 100 or 150 mg tablets. Price shown in your GLP-1 intake
A prescription sleep aid at a low dose, taken at bedtime when your clinician recommends it.
Prescription required. Compounded medications are not FDA-approved.
How to start
- Complete a short, secure online intake.
- A licensed U.S. clinician reviews your health history and decides whether tirzepatide or semaglutide is appropriate.
- If prescribed, your medication ships discreetly from a licensed U.S. pharmacy and arrives in 3 to 5 days.
Common questions
Is tirzepatide better than semaglutide?
In SURMOUNT-5, the FDA-approved tirzepatide regimen led to more weight loss on average than the FDA-approved semaglutide regimen. That makes it the natural first choice for many people, but a clinician decides what is right for you based on your health history.
Can I switch from semaglutide to tirzepatide?
Often, yes. Switching is a clinical decision, so mention your current medication and dose in your intake and your clinician will decide how to move you over.
Do the trial results apply to compounded tirzepatide?
No. SURMOUNT-5 studied FDA-approved products. Compounded tirzepatide was not studied, is not FDA-approved and is not the same as the FDA-approved product.
Does my price change when my dose goes up?
No. At Avono, tirzepatide and semaglutide each have one monthly price at every dose level.
This article is general education, not medical advice. Prescription required. A licensed clinician decides whether treatment is right for you. Compounded tirzepatide and semaglutide are prepared by licensed U.S. pharmacies and are not FDA-approved. Individual results vary.
Comparing GLP-1 options? Tirzepatide Injection · Semaglutide Injection
Explore care options
Hair loss, sexual health, skincare and longevity care from the same licensed U.S. clinicians, with one clear price and no clinician or membership fees.
Hair loss
Hair loss
Pills, sprays and topicals for thinning hair. Finasteride protects the hair you have, minoxidil helps it grow, and vitamin-based options suit people who want to avoid those drugs.
From $59/monthExplore hair options
Sexual health
Sexual health
ED treatment by how long it lasts: sildenafil for a few hours, tadalafil for up to 36. PT-141 is for low desire, in men and women.
From $60 for 6 dosesExplore sexual health
Skincare
Skincare
Prescription creams made for one concern each: acne, the marks it leaves, rosacea redness, dark spots and fine lines.
From $69/monthExplore skincare



